Description:

Oxidized LDL macrophages are recorded and stored via scavenger receptors. They convert them into foam cells as a result, and attach themselves to the vessel walls. The resulting inflammatory processes lead to the accumulation of other immunoreactive cells, the so-called atherosclerotic plaque. The break-up of atherosclerotic plaques and energy stores cause subsequent blood clots which are the most common cause of acute arterial occlusion. This enables practitioners to determine a patient's current atherogenic risk and assign treatments accordingly.

Tests for:

Oxidised LDL concentration

Symptoms and conditions:

• Chest pain
• Difficulty breathing
• Shortness of breath
• Rapid or irregular heartbeats
• Dizziness
• Light-headedness
• Extreme anxiety
• Nausea
• Vomiting
• Indigestion or heartburn
• Pain or discomfort in areas in the upper body, including the arms, back, stomach, left shoulder, jaw or neck
• Cold sweat
• Extreme weakness
• Atherosclerosis
• Arterial stenosis
• Arterial occlusion

Analytes measured:

Oxidised LDL

Method:

Enzyme-linked immunosorbent assay (ELISA)

Test type:

Cardiovascular: LDL, oxidised LDL, atherosclerosis

• 12 hours fasting serum (1 SST tube)
• Centrifugation: optional (recommended for patients outside Europe)
• Uncentrifuged: Draw on a Monday or Tuesday - must reach Nordic laboratories next day.
• Centrifuged: Must reach Nordic Laboratories within 7 days of draw.
• Keep at ambient temperature or refrigerated.
• Laboratory method: ELISA

Average processing time:

7-10 days